-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

The Science Behind HYMPAVZI (Marstacimab-hncq): Introducing an Innovative Treatment Option from Pfizer

Sponsor: Pfizer
Program: Product Theaters
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Diseases
Sunday, December 8, 2024: 8:00 AM-9:00 AM
Room 4 (San Diego Convention Center)
Speakers:
William Somers, PhD, Pfizer , Travis Gould, PhD, Pfizer Inc , Andrew Palladino, MD, Pfizer Inc and Jennifer Schumacher, PhD, Pfizer
Disclosures:
No relevant conflicts of interest to declare.
For in-Person participants only
See more of: Product Theaters
<< Previous Product Theater | Next Product Theater >>